Medical cannabis has a high discontinuation rate for treatment of musculoskeletal pain
1. Medical cannabis has a high discontinuation rate among patients with chronic musculoskeletal pain, particularly in the first few months,...
Hydroxychloroquine may have a treatment role for chronic inflammatory cardiomyopathy
1. Hydroxychloroquine plus prednisolone reduced the 12-month risk of the composite cardiovascular outcome by 72 percent compared with prednisolone alone....
Efficiency of remote monitoring and guidance in blood pressure management
1. Remote monitoring significantly reduced systolic blood pressure (BP) compared to usual care (−2.7 mm Hg, p = 0.002), especially...
Sleep quality patterns may predict outcomes in patients with heart failure:
1. Patients with severely disturbed sleep had the highest comorbidity burden, lowest ejection fraction, and poorest cognitive function. 2. Older...
Post-operative pain scores may be a predictor of 30-day infectious and non-infectious post-operative complications
1. Higher Post-operative Day 1 (POD1) pain scores were independently associated with increased 30-day infectious and non-infectious complications. 2. Infectious...
2 Minute Medicine Rewind August 11, 2025
Discontinuation rates and predictors of Medical Cannabis cessation for chronic musculoskeletal pain 1. Medical cannabis has a high discontinuation rate...
Use of pregabalin may increase risk of heart failure in geriatric patients
1. In patients aged 65 to 89 years of age with non-cancer chronic pain, use of pregabalin was associated with...
Antiseizure medications do not reduce the risk of epilepsy in patients with brain abscess
1. In patients with a brain abscess, use of antiseizure medications (ASM) was not associated with a statistical difference in...
Cervical medial branch blocks may offer therapeutic benefit for facet-mediated neck pain
1. A subset of patients undergoing cervical medial branch blocks experienced meaningful short- to medium-term pain and functional improvement that...
Ustekinumab may be superior to Vedolizumab for the treatment of Crohn’s disease
1. In patients with Crohn’s disease (CD) of the pouch following ileal-pouch anal anastomosis (IPAA) for medically-refractory ulcerative colitis (UC),...
